Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07058922

Acute Effects of Powdered Beetroot Extract Supplementation on the Microcirculation of Resistant Hypertensive Individuals

Status
Enrolling By Invitation
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
National Institute of Cardiology, Laranjeiras, Brazil · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Arterial hypertension is a major public health issue and is considered to be a new epidemic due to its high mortality and morbidity rates. Elevated blood pressure levels increase the risk of coronary artery disease, heart failure, stroke, chronic kidney disease and death. Dietary nitrate supplementation in the form of beetroot powder extract may offer a more accessible way to increase systemic nitric oxide availability and consequently promote vasodilation in these patients. However, studies are needed to assess its benefits in patients with hypertension.

Detailed description

Methods and Analyses: This is a double-blind, placebo-controlled clinical trial in which patients with hypertension will be randomly assigned to two groups to receive either nitrate powder supplementation or placebo for a duration of 60 days. The primary outcome will be the reduction in blood pressure levels. Secondary outcomes will include systemic microvascular reactivity and quality of life.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTevaluation of systemic microvascular reactivityEvaluation of systemic microvascular reactivity using laser speckle contrast imaging.
DIAGNOSTIC_TESTABPMAmbulatory blood pressure measuring: systolic, diastolic and mean arterial pressures
DIETARY_SUPPLEMENTbeetroot supplementA powdered beetroot extract supplement containing 400 mg of nitrate per dose will be used in the supplement group, administered orally at a daily amount of 10 g.

Timeline

Start date
2024-06-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-07-10
Last updated
2025-07-23

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT07058922. Inclusion in this directory is not an endorsement.